Universidad Autonoma de Nuevo Leon
Quick facts
Marketed products
Phase 3 pipeline
- Botulinum Toxins, Type A · Neurology; Dermatology; Aesthetics
Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis. - Doxophylline · Other
Phase 2 pipeline
- ropivacaine and midazolam epidural administration
- ropivacaine and midazolam intraarticular administration
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Universidad Autonoma de Nuevo Leon portfolio CI brief
- Universidad Autonoma de Nuevo Leon pipeline updates RSS
Frequently asked questions about Universidad Autonoma de Nuevo Leon
What are Universidad Autonoma de Nuevo Leon's marketed drugs?
Top marketed products include Acetaminophen 500mg, Betamethason Sodium Phosphate.
What is Universidad Autonoma de Nuevo Leon's pipeline?
Universidad Autonoma de Nuevo Leon has 2 drugs in Phase 3, 2 in Phase 2, 2 in Phase 1. Late-stage candidates include Botulinum Toxins, Type A, Doxophylline.